125459 | ORIGINAL — 2024 |

For more detailed technical specifications, you can access the full Guideline on Non-Clinical Studies for GTMPs via the official .

: This guideline is a cornerstone for developers of Advanced Therapy Medicinal Products (ATMPs) in the European Union. 125459

: Defining scientific principles for non-clinical studies specifically for gene therapies, which differ significantly from conventional pharmaceuticals. Key Safety Requirements : For more detailed technical specifications, you can access

: Characterizing potential immune responses to the viral vector or the new protein produced by the therapy. Key Safety Requirements : : Characterizing potential immune

This document outlines the essential safety and efficacy data that developers must generate during the "non-clinical" (animal or lab) phase to justify moving into human subjects.

Guideline on the Non-Clinical Studies Required before First ... - EMA

The number most commonly refers to a specific scientific guideline established by the European Medicines Agency (EMA) regarding the development of Gene Therapy Medicinal Products (GTMPs) .